vs
Side-by-side financial comparison of CLPS Inc (CLPS) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.
GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $82.8M, roughly 1.8× CLPS Inc). GLAUKOS Corp runs the higher net margin — 6.2% vs 0.2%, a 6.0% gap on every dollar of revenue.
CLPS Inc is a global information technology, consulting and digital solutions provider primarily serving the financial services sector, including banking, insurance and asset management clients. It also offers tailored tech solutions for retail, healthcare and e-commerce segments, with operating footprints across North America, Asia Pacific and Europe.
Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.
CLPS vs GKOS — Head-to-Head
Income Statement — Q4 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $82.8M | $150.6M |
| Net Profit | $183.0K | $9.4M |
| Gross Margin | 23.1% | 77.9% |
| Operating Margin | 0.2% | 9.0% |
| Net Margin | 0.2% | 6.2% |
| Revenue YoY | — | 41.2% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | $82.8M | — | ||
| Q1 26 | — | $150.6M | ||
| Q4 25 | — | $143.1M | ||
| Q3 25 | — | $133.5M | ||
| Q2 25 | — | $124.1M | ||
| Q1 25 | — | $106.7M | ||
| Q4 24 | $71.8M | $105.5M | ||
| Q3 24 | — | $96.7M |
| Q2 26 | $183.0K | — | ||
| Q1 26 | — | $9.4M | ||
| Q4 25 | — | $-133.7M | ||
| Q3 25 | — | $-16.2M | ||
| Q2 25 | — | $-19.7M | ||
| Q1 25 | — | $-18.1M | ||
| Q4 24 | $-993.5K | $-33.6M | ||
| Q3 24 | — | $-21.4M |
| Q2 26 | 23.1% | — | ||
| Q1 26 | — | 77.9% | ||
| Q4 25 | — | -1.1% | ||
| Q3 25 | — | 78.4% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 77.2% | ||
| Q4 24 | 21.9% | 72.9% | ||
| Q3 24 | — | 76.6% |
| Q2 26 | 0.2% | — | ||
| Q1 26 | — | 9.0% | ||
| Q4 25 | — | -97.7% | ||
| Q3 25 | — | -12.3% | ||
| Q2 25 | — | -18.3% | ||
| Q1 25 | — | -19.4% | ||
| Q4 24 | -1.3% | -27.2% | ||
| Q3 24 | — | -25.5% |
| Q2 26 | 0.2% | — | ||
| Q1 26 | — | 6.2% | ||
| Q4 25 | — | -93.4% | ||
| Q3 25 | — | -12.2% | ||
| Q2 25 | — | -15.8% | ||
| Q1 25 | — | -17.0% | ||
| Q4 24 | -1.4% | -31.8% | ||
| Q3 24 | — | -22.1% |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $-2.34 | ||
| Q3 25 | — | $-0.28 | ||
| Q2 25 | — | $-0.34 | ||
| Q1 25 | — | $-0.32 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $29.1M | $276.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $57.6M | $670.9M |
| Total Assets | $118.1M | $893.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | $29.1M | — | ||
| Q1 26 | — | $276.7M | ||
| Q4 25 | — | $90.8M | ||
| Q3 25 | — | $98.2M | ||
| Q2 25 | — | $100.8M | ||
| Q1 25 | — | $114.3M | ||
| Q4 24 | $31.2M | $169.6M | ||
| Q3 24 | — | $100.1M |
| Q2 26 | $57.6M | — | ||
| Q1 26 | — | $670.9M | ||
| Q4 25 | — | $656.2M | ||
| Q3 25 | — | $769.5M | ||
| Q2 25 | — | $765.1M | ||
| Q1 25 | — | $764.0M | ||
| Q4 24 | $63.9M | $766.9M | ||
| Q3 24 | — | $668.5M |
| Q2 26 | $118.1M | — | ||
| Q1 26 | — | $893.3M | ||
| Q4 25 | — | $893.5M | ||
| Q3 25 | — | $999.4M | ||
| Q2 25 | — | $987.0M | ||
| Q1 25 | — | $966.2M | ||
| Q4 24 | $110.0M | $974.8M | ||
| Q3 24 | — | $926.5M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
